Complex Generic Pipeline

About Hikma Pharmaceuticals

Hikma Pharmaceuticals is a revenue-generating, publicly traded pharmaceutical company with a mission to improve global access to high-quality medicines. It operates through three distinct, market-leading segments: a top-five global Injectables business, a rapidly growing US-focused Generics (Hikma Rx) division, and a Branded business that is the largest pharmaceutical company by sales in the MENA region. The company's strategy focuses on striving for operational excellence, diversifying its product pipeline, and empowering its people, supported by a culture of innovation, caring, and collaboration. Recent achievements include launching 84 products in 2025 and implementing strategic investments to drive future growth.

Therapeutic Areas